IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-05-06 (finimize.com)
IQVIA Ups Revenue Forecast After Exceeding Profit Estimates -
IQVIA's robust demand for its drug research services and a favorable currency exchange rate contributed to its strong first-quarter performance.
Read more
2025-02-18 (marketbeat.com)
Callahan Advisors LLC Grows Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Callahan Advisors LLC increased its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 35,719 shares of the medical research company's stock after purchasing an
Read more
2025-02-15 (marketbeat.com)
Hickory Asset Management Inc. Makes New $941,000 Investment in IQVIA Holdings Inc. (NYSE:IQV)
Hickory Asset Management Inc. purchased a new stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 4,787 shares of the medical research company's stock, valued a
Read more
2025-02-07 (sharewise.com)
Iqvia Stock: Q4 Growth Signals Strong 2025 Outlook
Iqvia demonstrated robust performance in the fourth quarter of 2024, with revenue climbing 2.3% year-over-year to reach $3.96 billion. The company's Technology & Analytics Solutions segment emerged
Read more
2025-01-29 (marketbeat.com)
Smith Group Asset Management LLC Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Smith Group Asset Management LLC acquired a new stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 8,224 shares of the medical research company's stock, valued at app
Read more
2025-01-26 (marketbeat.com)
Asio Capital LLC cut its position in IQVIA Holdings Inc. (NYSE:IQVIA). (NYSE:IQV)
Asio Capital LLC lowered its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 59.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,304 shares of the medical research company's stock
Read more
2025-01-22 (biospace.com)
IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025 -
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 6, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
Read more
2025-01-06 (marketbeat.com)
Nordea Investment Management AB Increases Position in IQVIA Holdings Inc. (NYSE:IQV)
Nordea Investment Management AB raised its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 47.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,405,281 shares of the medical resea
Read more
2025-01-05 (marketbeat.com)
Everence Capital Management Inc. Sells 2,778 Shares of IQVIA Holdings Inc. (NYSE:IQV)
Everence Capital Management Inc. lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 48.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 2,920 shares of the medical research company's stock after selling 2,778 shares during th
Read more
2024-12-29 (marketbeat.com)
IQVIA Holdings Inc. (NYSE:IQV) Stock Position Raised by JPMorgan Chase & Co. (NYSE:IQV).
JPMorgan Chase & Co. raised its holdings in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 46.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,845,711 shares of the medical research company's stock after buying an ad
Read more
2024-12-22 (marketbeat.com)
M&T Bank Corp Lowers Holdings in IQVIA Holdings Inc. (NYSE:IQV)
M&T Bank Corp reduced its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 27.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 69,410 shares of the medical research company'
Read more
2024-12-18 (newscj.com)
Dongwha Pharm's Pancol-S achieves first place in cold medicine market sales for two consecutive years < Company/Industry < Economy < Text of article -
[Cheonji Ilbo = Reporter Hong Bo-young] Dongwha Pharmaceutical announced on the 17th that its comprehensive cold medicine 'Pancol-S' has ranked first in sales in the cold medicine market for two consecutive years. Recently announced 2024 IQVIA data from the 4th quarter of 2023 to 2024 In the third quarter, Pancol S sales recorded 35.8 billion won, maintaining its top spot in sales. This is about 14
Read more